2022_Oct_PODD_Boston_ Skyscraper2

About

Shahid Uddin, PhD, is currently Director of Drug Product, Formulation & Stability within the Chemistry, Manufacturing and Controls department at Immunocore. Dr Uddin is responsible for commercialisation and bringing research candidates into the clinic. Prior to this, Dr Uddin held the position of Head of Formulation at MedImmune (AstraZeneca), where he supported the biologics portfolio covering mAbs, peptides, bispecifics and other proteins. He has extensive experience in preformulation/formulation, forced degradation and delivery of biologics both for early- and late-stage programmes.

Top